Indian pharma Industry to log 8-10% revenue growth in FY24

India’s pharmaceutical industry is expected to have a revenue growth of 8-10 percent in Financial Year 2024 (FY24), ratings agency ICRA has said in a report. Growth is likely to be driven by price increases, new products, and health care services expanding in semi-urban and rural areas, said the report based on data from ICRA’s sample […]
Unlocking Pharma Manufacturing Agility

Source: Economic Times Pharma manufacturing faces unique market and operational challenges. When an attempt is made to manage this high-uncertainty environment with the typical method of monthly production planning, it precipitates a vicious loop of issues. Only a dynamic approach that ensures flexibility on the shop floor can sustainably ensure reliability and high output. In FY […]
FM announces HPV vaccination advocacy in Union Budget 2024

Source: Economic Times HPV vaccination inequities and the lack of access to a national HPV vaccination drive have aggravated the situation. Today while announcing the interim Budget for 2024, Nirmala Sitharaman, Finance Minister, Government of India addressed this scenario. She said, “Government will advocate for vaccination of girls aged 9-14 against cervical cancer.” Incidence is […]
Top 10 most anticipated drug launches of 2024

Source: fiercepharma Every year, we tap Evaluate’s annual preview report to assess the biggest potential new drugs of the year ahead. Typically, major pharmaceutical and biotechnology companies are featured, each presenting potential blockbuster launches. In 2024, however, things are set to play out a little differently. The most anticipated drug comes from a biotech that […]